Hyaluronidase (Keratase) - ISTA

Drug Profile

Hyaluronidase (Keratase) - ISTA

Alternative Names: Keratase

Latest Information Update: 13 May 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator ISTA Pharmaceuticals
  • Class Antineoplastics; Glycoside hydrolases; Polysaccharide lyases
  • Mechanism of Action Hyaluronic acid modulators; Hyaluronidase replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Cataracts

Most Recent Events

  • 22 Feb 2005 Suspended - Phase-II for Cataracts in USA (Ophthalmic)
  • 25 Aug 2003 This compound is still in active development
  • 18 Jul 2001 Phase-II clinical trials for Cataracts in USA (Ophthalmic)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top